Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a prospective case control study that compares the initial immune response with severity and outcome in patients with acute pancreatitis.
This is a prospective case control study that compares the initial immune response with severity and outcome in patients with acute pancreatitis. Therefore, the investigators aim to determine whether etiology of acute pancreatitis, segregates with candidate genetic polymorphisms and their m-RNA expression, as well as whether functional polymorphisms in inflammation regulating genes predict a more severe outcome in acute pancreatits. The investigators anticipate that based on our results that we will provide a more accurate predictor of the clinical course of acute pancreatits and help direct more aggressive or cytokine specific treatment of patients at greater risk of a more severe form of the disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Subjects with acute pancreatitis | Subjects with acute pancreatitis | ||
| Subjects with previous attack | Subjects with previous attack | ||
| Controls | Controls |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Severe Acute Pancreatitis (defined as persistent organ failure) | To compare the initial immune response in patients who developed mild vs. severe disease. To determine whether functional polymorphisms in inflammation regulating genes predicts a more severe outcome in acute pancreatitis. | 1 year |
Not provided
Not provided
Inclusion Criteria:
Diagnosis of acute pancreatitis by both: Abdominal pain or abdominal localizing signs AND Elevated amylase levels by at-least three times the upper limit of normal and/or elevated lipase levels by at-least three times the upper limit of normal (25, 26). Acute pancreatitis must be defined by 2 of the 3 following criteria:
Inclusion criteria for Controls (all three) Males and females of 18 years of age and older. a. Unrelated family member or a friend of the subject or a patient having blood drawn in general medicine outpatient clinic, without a history of pancreatitis, OR Willingness to participate in the study and sign the informed consent.
Additional Inclusion Criteria for subjects with a previous attack of acute pancreatitis:
age criteria as defined above.
- Previous severe attack of severe acute pancreatitis requiring a ICU stay of at least 48 hours or evidence of pancreatic necrosis on computerized tomography.
Willingness to participate and sign informed consent
Exclusion Criteria:
Persons unwilling to sign the informed consent Disorientation secondary to irreversible organic brain damage. Mean corpuscular volume (MCV) of less than 77 in all children of 18 years or younger.
Blood transfusion within one week of enrollment Chronic Pancreatitis History of pancreatic cancer History of cancer requiring chemotherapy or radiation within the past 1 year History of organ transplant Subject is a prisoner Pancreatitis due to multiple trauma or surgical complications
Exclusion criteria for Controls:
Persons unwilling to sign the informed consent
Not provided
Not provided
Not provided
Both males and females, over 1 year of age.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| George Papachristou, MD | Ohio State University | Study Chair |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33955376 | Derived | Langmead C, Lee PJ, Paragomi P, Greer P, Stello K, Hart PA, Whitcomb DC, Papachristou GI. A Novel 5-Cytokine Panel Outperforms Conventional Predictive Markers of Persistent Organ Failure in Acute Pancreatitis. Clin Transl Gastroenterol. 2021 May 6;12(5):e00351. doi: 10.14309/ctg.0000000000000351. | |
| 32877220 | Derived |
Not provided
Not provided
If shared, all individual identifiers will be removed.
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010195 | Pancreatitis |
| D009102 | Multiple Organ Failure |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D012769 | Shock |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Serum and DNA and urine samples will be collected and stored without personal identifiers (e.g. using a unique laboratory number or bar code) for future research involving pancreatic diseases to include pancreatitis and pancreatic cancer. Stored biospecimens collected for htis protocol may be shared in a de-identified manner with outside investigators with the approval of the principal investigator.
| Komara NL, Paragomi P, Greer PJ, Wilson AS, Breze C, Papachristou GI, Whitcomb DC. Severe acute pancreatitis: capillary permeability model linking systemic inflammation to multiorgan failure. Am J Physiol Gastrointest Liver Physiol. 2020 Nov 1;319(5):G573-G583. doi: 10.1152/ajpgi.00285.2020. Epub 2020 Sep 2. |
| 30569031 | Derived | Dugum M, Gougol A, Paragomi P, Gao X, Matta B, Yazici C, Tang G, Greer P, Pothoulakis I, O'Keefe SJD, Whitcomb DC, Yadav D, Papachristou GI. Association of Dietary Habits with Severity of Acute Pancreatitis. Curr Dev Nutr. 2018 Oct 8;2(12):nzy075. doi: 10.1093/cdn/nzy075. eCollection 2018 Dec. |
| D013568 |
| Pathological Conditions, Signs and Symptoms |